Escolar Documentos
Profissional Documentos
Cultura Documentos
Research Paper
Centre for Musculoskeletal Research, Department of Occupational and Public Health Sciences, Faculty of Health and
Occupational Studies, University of Gvle, Gvle, Sweden, 2Alfta Research Foundation, Alfta, Sweden, 3Department of
Community Medicine and Rehabilitation, Physiotherapy, Ume University, Ume, Sweden, 4Department of Health and Caring
Sciences, Faculty of Health and Occupational Studies, University of Gvle, Gvle, Sweden, and 5Department of Public Health
and Caring Sciences, Uppsala University, Uppsala, Sweden
Background
Musculoskeletal disorders (MSDs) are complex phenomena
that, to be fully understood, require knowledge from different
Correspondence: Birgitta Wiitavaara, Centre for Musculoskeletal Research, Department of Occupational and Public Health Sciences, Faculty of Health
and Occupational Studies, University of Gvle, SE-801 76 Gvle, Sweden. Tel: +46 (0) 26 648405. Fax: +46 (0) 26 648686. E-mail: biawia@hig.se
(Accepted September 2011)
934
Methods
Design
This cross-sectional study is based on data from a baseline
measurement, collected in a randomised controlled study
(RCT: ISRCTN trial registration number 92199001) of neckshoulder treatment among women during 2008 in Sweden.
The study was approved by the regional ethical review board
in Uppsala (D-nr. 2007-206).
Sample
The sample consisted of 117 participants, all female, (mean
age 51.3; range 2565; SD 8.8), with non-specific neckshoulder pain. We define non-specific neck-shoulder pain
as pain in the neck and surrounding tissues. This includes
pain from the neck/shoulder muscles, but not complaints
related to the gleno-humeral joints. The sample constituted
a convenience sample for an initial factor analysis, as they
were recruited for a RCT-study with specific aims focusing
women with neck-shoulder pain. The participants reported
pain durations of at least 3 months (mean duration 139
months; range 6456; SD 95.5). Women with fibromyalgia,
whiplash or other concurrent chronic disease were excluded
(for further information on criteria for inclusion/exclusion,
turn to the study protocol http://www.controlled-trials.com/
ISRCTN92199001).
Measures
The starting point for the selection of outcome measures was
the recommended four core domains [7]: (1) pain intensity,
(2) physical functioning, (3) emotional functioning and (4)
general improvement. However, the recommended measure
for the domain general improvement, the Patient Global
Impression of Change Scale [8] is only administered after
treatment and was therefore excluded. The recommended
outcome measures for the remaining three domains are (1)
a numeric rating scale (NRS), (2) the Brief Pain Inventory
[9] or the Multidimensional Pain Inventory; MPI [10] (3)
the Beck Depression Inventory (BDI) [11,12] or the Profile
of Mood States (POMS) [13]. For details on selected outcome
measures, see below.
2012 Informa UK, Ltd.
Statistical analyses
All analyses were performed using PASW statistics for
Windows 18.0 (SPSS). Initially Cronbachs was calculated
to determine the internal consistency of the instruments total
and subscale scores (Table I).
Thereafter a factor analysis was performed in two steps,
using principal component analysis (PCA) for extraction and
orthogonal Varimax rotation with Kaiser normalisation to
clarify factor structure. The two step procedure was chosen
to get an acceptable subject-to-variable ratio in the analysis.
Kaiser-Meyer-Olkin measure of sampling adequacy (KMO)
and Bartletts test were used to determine the adequacy of
performing a factor analysis on the selected data (Table II).
The KMOs were satisfactorily above 0.70 [28], and Bartletts
test showed significant results for all three questionnaires
(p <0.05).
Table I. Reliability of the questionnaires (n=117).
Questionnaire
MPI-S overall score
MPI-S pain intensity
MPI-S interference
MPI-S life control
MPI-S affective distress
MPI-S support
MPI-S responses
from significant others:
punishing
MPI-S responses
from significant others:
solicitous
MPI-S responses
from significant others:
distracting
MADRS-S overall
score
RPWS overall score
RPWS environmental
mastery
RPWS self-acceptance
RPWS positive
relations
RPWS purpose in life
RPWS personal growth
RPWS autonomy
0.86
0.87
0.95
0.77
0.79
0.86
0.82
2.37
3.08
2.03
3.71
2.19
3.21
0.86
3.84
0.36
1.67
1.29
0.37
0.27
0.47
112
0.85
2.36
1.72
112
0.75
2.53
0.82
115
0.77
1.05
1.85
116
117
0.79
0.57
4.46
4.61
1.39
0.10
116
116
0.74
0.61
4.47
4.62
1.02
0.84
117
117
116
0.35
0.61
0.58
4.46
4.49
4.12
1.33
1.10
0.42
Questionnaire
MPI-S
MADRS-S
RPWS
0.000
0.000
0.000
MPI-S: Multidimensional Pain Inventory- Swedish version: MADRS-S: Montgomery sberg Depression Rating Scale, RPWS: Ryff s Psychological Well-being Scale.
(ap<0.05).
Results
Factor analysis
In the separate PCA of MPI-S seven factors were extracted
that explained 70.8% of the variance. The PCA of MADRS-S
resulted in a 3-factor solution, which explained 63.2% of the
variance, whereas the PCA of RPWS suggested a 5-factor
solution explaining 61.2% of the variance. The 36 items that
had a factor loading of 0.70 or more in the separate PCAs
were thereafter included in a joint PCA with Varimax rotation. The results suggested a 9-factor solution including items
that explained 68.9% of the variance. The component matrix
before rotation is presented in Table III, the rotated component matrix and communalities are presented in Table IV and
the total variance explained in Table V.
Items and factor structure of the 9-factor solution including 29 items loading 0.60 are shown in table VI. The resulting factors were; interference (of pain) (1), solicitous and
distracting responses from significant others (2), mood and
feelings about self and relations (3), pain intensity (4), punishing responses from significant others (5), personal growth
(6), life control (7), sleep (8) and appetite (9) (for details see
Table VI).
Discussion
The intention of the study was to take the first step in the
development of a clinically useful short-form questionnaire
for measurement of musculoskeletal symptoms, based on
recommendations on valid and reliable outcome measures.
According to the final factor analysis, the short-form questionnaire should constitute of nine factors (in all 29 items)
measuring four domains; pain intensity, physical functioning,
Disability & Rehabilitation
1
mpiP1Q4b
mpiP1Q10
mpiP1Q21
mpiP1Q8
mpiP1Q12
mpiP1Q3
mpiP1Q2
mpiP1Q19
mpiP1Q17
mpiP1Q9
mpiP1Q20
mpiP1Q7
mpiP1Q15
rpwsFinalf55
rpwsFinalf7
madrsQ8
mpiFinalP1Q6
mpiP2Q1
mpiP2Q11
mpiP2Q6
mpiP2Q10
mpiP2Q4
mpiP2Q12
madrsQ7
madrsQ9
rpwsFinalQ65
rpwsFinalQ76
rpwsQ28
mpiP1Q1
mpiP2Q5
mpiP2Q8
mpiP1Q16
rpwsQ80
rpwsFinalQ11
madrsQ4
madrsQ3
0.859
0.836
0.810
0.790
0.763
0.756
0.750
0.741
0.687
0.665
0.630
0.594
0.500
0.487
0.481
0.472
0.435
0.102
0.148
0.061
0.053
0.171
0.179
0.429
0.374
0.155
0.128
0.140
0.501
0.306
0.154
0.282
0.101
0.075
0.189
0.235
2
0.032
0.193
0.070
0.130
0.080
0.132
0.132
0.133
0.114
0.173
0.333
0.010
0.212
0.300
0.360
0.188
0.417
0.795
0.747
0.741
0.734
0.723
0.681
0.084
0.296
0.211
0.300
0.316
0.012
0.318
0.144
0.131
0.167
0.268
0.012
0.036
3
0.253
0.098
0.142
0.177
0.075
0.185
0.256
0.215
0.229
0.186
0.035
0.290
0.220
0.329
0.371
0.358
0.174
0.207
0.345
0.185
0.278
0.322
0.375
0.585
0.497
0.477
0.421
0.076
0.241
0.321
0.413
0.079
0.058
0.095
0.168
0.076
4
0.013
0.167
0.077
0.290
0.003
0.090
0.024
0.217
0.190
0.268
0.208
0.314
0.179
0.264
0.198
0.245
0.336
0.021
0.056
0.129
0.112
0.008
0.023
0.012
0.010
0.024
0.340
0.508
0.397
0.214
0.331
0.086
0.440
0.041
0.131
0.091
Component
5
0.013
0.102
0.132
0.009
0.122
0.106
0.197
0.089
0.230
0.081
0.120
0.483
0.064
0.242
0.064
0.356
0.218
0.048
0.045
0.127
0.032
0.025
0.019
0.087
0.159
0.270
0.225
0.092
0.561
0.483
0.452
0.211
0.024
0.089
0.104
0.127
6
0.048
0.117
0.174
0.073
0.167
0.052
0.187
0.061
0.009
0.004
0.120
0.086
0.348
0.029
0.129
0.069
0.078
0.061
0.019
0.060
0.074
0.073
0.212
0.074
0.054
0.160
0.086
0.253
0.045
0.324
0.360
0.602
0.494
0.316
0.361
0.070
7
0.018
0.026
0.085
0.031
0.135
0.114
0.057
0.148
0.243
0.005
0.196
0.123
0.070
0.077
0.189
0.175
0.315
0.145
0.102
0.086
0.199
0.132
0.075
0.076
0.159
0.125
0.349
0.419
0.016
0.273
0.098
0.054
0.059
0.612
0.025
0.323
8
0.048
0.022
0.038
0.019
0.164
0.024
0.106
0.126
0.032
0.073
0.017
0.017
0.088
0.063
0.023
0.095
0.071
0.131
0.034
0.048
0.124
0.023
0.017
0.191
0.241
0.353
0.329
0.171
0.041
0.063
0.398
0.103
0.002
0.101
0.690
0.307
9
0.002
0.122
0.152
0.116
0.089
0.011
0.040
0.013
-0.080
0.324
0.313
0.073
0.137
0.182
0.016
0.123
0.132
0.117
0.015
0.130
0.256
0.073
0.036
0.118
0.013
0.069
0.037
0.332
0.241
0.007
0.046
0.175
0.167
0.279
0.293
0.463
1
mpiP1Q10b
mpiP1Q8
mpiP1Q4
mpiP1Q9
mpiP1Q19
mpiP1Q17
mpiP1Q21
mpiP1Q12
mpiP1Q2
mpiP1Q3
mpiP2Q10
mpiP2Q1
mpiP2Q11
mpiP2Q4
mpiP2Q12
mpiP2Q6
mpiFinalP1Q6
rpwsFinalQ55
rpwsFinalQ7
madrsQ8
madrsQ9
mpiP1Q20
madrsQ7
mpiP1Q1
mpiP1Q7
mpiP2Q8
mpiP2Q5
rpwsFinalQ65
rpwsQ28
rpwsQ80
rpwsFinalQ76
mpiP1Q16
mpiP1Q15
rpwsFinalQ11
madrsQ3
madrsQ4
0.858
0.853
0.800
0.798
0.794
0.786
0.762
0.729
0.695
0.678
0.023
0.120
0.147
0.122
0.104
0.013
0.125
0.222
0.165
0.188
0.128
0.380
0.152
0.267
0.412
0.023
0.139
0.055
0.081
0.072
0.048
0.095
0.233
0.041
0.175
0.037
2
0.169
0.075
0.059
0.066
0.087
0.020
0.090
0.068
0.096
0.107
0.818
0.810
0.805
0.802
0.789
0.772
0.193
0.086
0.092
0.065
0.008
0.177
0.203
0.025
0.028
0.028
0.149
0.024
0.155
0.062
0.029
0.022
0.028
0.154
0.005
0.071
3
0.200
0.063
0.252
0.008
0.118
0.078
0.296
0.276
0.020
0.142
0.024
0.130
0.051
0.011
0.008
0.118
0.735
0.708
0.696
0.681
0.578
0.574
0.544
0.043
0.067
0.040
0.124
0.284
0.111
0.080
0.230
0.119
0.415
0.083
0.044
0.130
Component
5
0.048
0.075
0.304
0.087
0.112
0.068
0.201
0.074
0.404
0.344
0.087
0.045
0.156
0.004
0.059
0.162
0.214
0.036
0.110
0.046
0.163
0.371
0.151
0.852
0.761
0.021
0.125
0.007
0.054
0.070
0.020
0.219
0.167
0.047
0.098
0.048
0.070
0.125
0.004
0.018
0.036
0.037
0.008
0.104
0.001
0.024
0.075
0.077
0.058
0.050
0.005
0.068
0.075
0.057
0.211
0.022
0.293
0.034
0.319
0.109
0.044
0.839
0.822
0.523
0.021
0.013
0.364
0.061
0.066
0.073
0.018
0.061
6
0.020
0.115
0.021
0.008
0.163
0.054
0.106
0.132
0.063
0.093
0.024
0.143
0.111
0.018
0.047
0.069
0.123
0.071
0.071
0.055
0.030
0.165
0.062
0.118
0.047
0.144
0.010
0.059
0.843
0.597
0.522
0.185
0.031
0.008
0.145
0.037
7
0.011
0.046
0.003
0.175
0.005
0.030
0.157
0.074
0.248
0.149
0.259
0.039
0.054
0.094
0.194
0.000
0.112
0.122
0.027
0.132
0.207
0.182
0.195
0.113
0.164
0.206
0.027
0.269
0.088
0.298
0.275
0.652
0.501
0.282
0.228
0.196
Communalities
0.038
0.042
0.059
0.122
0.073
0.240
0.061
0.113
0.117
0.121
0.057
0.130
0.038
0.117
0.059
0.061
0.076
0.056
0.106
0.317
0.164
0.090
0.098
0.073
0.083
0.012
0.100
0.056
0.032
0.210
0.259
0.001
0.097
0.724
0.608
0.003
0.013
0.012
0.071
0.038
0.110
0.048
0.097
0.161
0.009
0.051
0.066
0.101
0.011
0.028
0.099
0.008
0.050
0.147
0.036
0.072
0.227
0.068
0.258
0.002
0.076
0.242
0.029
0.321
0.074
0.041
0.292
0.164
0.107
0.116
0.141
0.847
0.814
0.776
0.808
0.696
0.694
0.711
0.766
0.690
0.659
0.735
0.744
0.716
0.758
0.650
0.690
0.685
0.532
0.562
0.844
0.798
0.681
0.718
0.829
0.761
0.585
0.633
0.602
0.786
0.505
0.606
0.595
0.512
0.772
0.540
0.688
0.658
Extraction method: principal component analysis. Rotation method: Varimax with Kaiser Normalization.
aRotation converged in 11 iterations.
Bold numbers=selected items.
bmadrs, Montgomery sberg Depression Rating Scale; mpi, Multidimensional Pain Inventory-Swedish version; P, part of questionnaire; Q, question number; rpws, Ryff s Psychological Well-being Scale.
may be advantageous to use direct questions regarding physical functioning (e.g. ability to bend the neck). This notion
is corroborated by studies on sensorimotor dysfunctions of
women with neck pain, showing that self-rated difficulties of
neck movement were associated with reduced head- and arm
movement performance [34,35].
Nine items encompassing mood and feelings about self
and relations, sleep, appetite, personal growth, and life control were attributed to emotional functioning. These items are
related to important aspects affected by pain, disclosed in an
extensive survey by IMMPACT on chronic pain conditions
including MSDs; enjoyment of life in general, emotional
well-being, fatigue, weakness and sleep related problems
[6]. Relations with family, relatives or significant others were
Component
Total
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
8.815
4.581
2.803
1.687
1.669
1.539
1.371
1.242
1.092
0.998
0.981
0.935
0.808
0.753
0.704
0.671
0.565
0.543
0.453
0.417
0.398
0.384
0.326
0.289
0.270
0.253
0.217
0.207
0.184
0.165
0.150
0.143
0.132
0.102
0.091
0.062
Initial Eigenvalues
% of variance Cumulative %
24.485
12.725
7.785
4.685
4.635
4.276
3.807
3.449
3.032
2.773
2.726
2.598
2.243
2.091
1.954
1.864
1.571
1.509
1.258
1.158
1.104
1.066
0.905
0.802
0.750
0.703
0.602
0.576
0.511
0.460
0.418
0.399
0.367
0.282
0.254
0.173
24.485
37.210
44.995
49.681
54.316
58.592
62.400
65.849
68.881
71.654
74.380
76.979
79.222
81.313
83.267
85.131
86.702
88.211
89.469
90.628
91.732
92.798
93.702
94.504
95.254
95.957
96.560
97.136
97.647
98.107
98.525
98.923
99.290
99.573
99.827
100.000
8.815
4.581
2.803
1.687
1.669
1.539
1.371
1.242
1.092
6.793
4.131
3.684
2.185
2.117
1.624
1.598
1.379
1.287
24.485
12.725
7.785
4.685
4.635
4.276
3.807
3.449
3.032
24.485
37.210
44.995
49.681
54.316
58.592
62.400
65.849
68.881
18.871
11.474
10.233
6.068
5.882
4.510
4.438
3.830
3.575
18.871
30.345
40.578
46.646
52.528
57.038
61.476
65.306
68.881
for a level of at least 80%; otherwise, a reduction of low-loading factors is necessary. In the present study, the level of total
variance explained was judged as satisfactory with a factor
loading over 0.60. Henson and Roberts [29] discussed levels
of total variance explained in a review article on the use of
exploratory factor analysis. They presented substantially lower
levels of variance explained (on average 52%) and questioned
whether levels of 75% or higher are reasonable expectations in
for example psychological research.
In the present study we made some alternative choices
regarding questionnaires compared to those recommended by
IMMPACT. Regarding pain intensity, the use of a NRS (010)
is recommended. In this study pain intensity was measured
using the two items that are included in MPI-S. The advantage
in doing so is that these two items make it possible to measure
variability in pain intensity, as they ask for pain at the moment
and during the last week. A single NRS only measures pain at
2012 Informa UK, Ltd.
Factor Label
Item
MPI P1Q10a
0.858
MPI P1Q8
0.853
MPI P1Q4
0.800
MPI P1Q9
MPI P1Q17
MPI P1Q19
MPI P1Q21
0.789
0.786
0.794
0.762
MPI P1Q12
0.729
MPI P1Q2
MPI P1Q3
Solicitous and
MPI P2Q1
distracting responses MPI P2Q11
from significant others
MPI P2Q12
MPI P2Q6
MPI P2Q10
MPI P2Q4
Mood and feelings
MPI P1Q6
about self and
RPWS Q 55
relations
RPWS Q 7
MADRS Q8
0.695
0.678
0.810
0.805
0.789
0.772
0.818
0.802
0.735
0.708
0.696
0.681
Interference of pain
MPI P1Q1
MPI P1Q7
Punishing responses
MPI P2Q8
from significant others MPI P2Q5
Personal growth
RPWS Q28
0.852
0.761
0.839
0.822
0.843
7
8
Life control
Sleep
MPI P1Q16
RPWS Q 11
MADRS Q3
0.652
0.724
0.608
Appetite
MADRS Q4
0.847
Pain intensity
aMADRS,
Montgomery sberg Depression Rating Scale; MPI- S, Multidimensional Pain Inventory- Swedish version; P, part of questionnaire, Q, question number; RPWS, Ryff s
Psychological Well-being Scale.
7.
8.
9.
10.
11.
12.
Conclusions
From the starting point with three questionnaires including
61 items the factor analyses resulted in a stable 9-factor solution including 29 items. The result constitutes the first step in
the development of a short-form questionnaire that contains
core dimensions of symptoms and functioning for people
with neck-shoulder disorders. Further studies with samples of
both men and women and of other musculoskeletal disorders
would additionally contribute to the development of valid
outcome measures.
Acknowledgements
The authors would like to thank Hans Hgberg, statistician at the Centre for Research and Development, County
Council of Gvleborg/Uppsala University, for statistical
advice and discussions regarding the outline, computation
and results of analysis. The authors also would like to thank
Maria Frykman for excellent administrative work. And
finally, thanks to Marina Heiden, researcher at the Centre
for Musculoskeletal Research, University of Gvle, for proof
reading.
Declaration of Interest: The authors declare that they have
no competing interests. The study was funded by Alfta
Research Foundation and by grants from the Swedish Council
for Working Life and Social Research (20061162) and
Lnsfrskringar Forskning och Framtid (511010/06).
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
References
1. Gatchel RJ, Peng YB, Peters ML, Fuchs PN, Turk DC. The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol Bull 2007;133:581624.
2. SBU, editor. Methods for long term pain treatment. Stockholm: The
Swedish Council on Technology Assessment in Health Care; 2006.
3. Wiitavaara B, Bjrklund M, Brulin C, Djupsjbacka M. How well do
questionnaires on symptoms in neck-shoulder disorders capture the
experiences of those who suffer from neck-shoulder disorders? A content analysis of questionnaires and interviews. BMC Musculoskelet
Disord 2009;10:30.
4. Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr
DB, Cleeland C, etal. Core outcome domains for chronic pain clinical
trials: IMMPACT recommendations. Pain 2003;106:337345.
5. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP,
Katz NP, Kerns RD, et al.; IMMPACT. Core outcome measures for
chronic pain clinical trials: IMMPACT recommendations. Pain
2005;113:919.
6. Turk DC, Dworkin RH, Revicki D, Harding G, Burke LB, Cella D,
Cleeland CS, et al. Identifying important outcome domains for
27.
28.
29.
30.
31.
32.
33.
Copyright of Disability & Rehabilitation is the property of Taylor & Francis Ltd and its content may not be
copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written
permission. However, users may print, download, or email articles for individual use.